MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.
Vergunst, Clarissa E. 1; Gerlag, Danielle M. 1; von Moltke, Lisa 2; Karol, Michael 3; Wyant, Tim 2; Chi, Xuedong 2; Matzkin, Ellen 4; Leach, Timothy 2; Tak, Paul P. 1
[Article]
Arthritis & Rheumatism.
60(12):3572-3581, December 2009.
(Format: HTML, PDF)